Stay updated with breaking news from Nasdaq Agle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Carlyle Group Inc. bought a new stake in shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 240,500 shares of the biotechnology company’s stock, valued at approximately $69,000. Carlyle Group Inc. owned approximately […]
Shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Free Report) have received an average recommendation of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month […]
StockNews.com lowered shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research report report published on Sunday morning. Several other equities research analysts have also recently weighed in on the company. Jonestrading reiterated a hold rating on shares of Aeglea BioTherapeutics in a research report on […]
StockNews.com downgraded shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a hold rating to a sell rating in a research report released on Sunday. A number of other research analysts have also weighed in on AGLE. Wells Fargo & Company lowered shares of Aeglea BioTherapeutics from an overweight rating to an equal weight rating […]
Shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Rating) have earned a consensus rating of “Hold” from the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating. The average 12 month price target among analysts that have issued ratings on the stock […]